Clinical Trial Update: Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism [Phase 2]

View source ↗

Summary

Phase 2 trial comparing recombinant human rhPTH(1-34) to alfacalcidol/hydrochlorothiazide in severe primary hypoparathyroidism with hypercalciuria under treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Hypocalcemia
• Hypoparathyroidism

Drugs mentioned

• Alfacalcidol (alfacalcidol)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• rhPTH(1-34) recombinant human (parathyroid hormone analog, 1-34 fragment)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment | Phase 2 | Status: COMPLETED